C Escudero-Lourdes, I Alvarado-Morales… - Stem cell reviews and …, 2022 - Springer
Cancer stem cells (CSCs) and cells in a cancer stem cell-like (CSCL) state have proven to be responsible for tumor initiation, growth, and relapse in Prostate Cancer (PCa) and other …
J Wang, J Li, L Yin, T Pu, J Wei, V Karthikeyan, TP Lin… - Oncogene, 2022 - nature.com
Neuroendocrine prostate cancer (NEPC), a lethal subset of prostate cancer, is characterized by loss of AR signaling and resulting resistance to AR-targeted therapy during …
L Verlinden, S Doms, I Janssens, MB Meyer… - Frontiers in …, 2023 - frontiersin.org
Introduction Neuropilin 2 (NRP2) mediates the effects of class 3 semaphorins and vascular endothelial growth factor and is implicated in axonal guidance and angiogenesis. Moreover …
R Dhupar, AA Powers, SH Eisenberg… - Journal of Clinical …, 2024 - mdpi.com
Immunity has evolved to balance the destructive nature of inflammation with wound healing to overcome trauma, infection, environmental insults, and rogue malignant cells. The …
SA Mullen, D Das, N Ziamiavaghi, R High… - The …, 2024 - Wiley Online Library
Abstract Background Neuropilin 2 (NRP2) expression in tissue is an independent prognostic factor for aggressive prostate cancer. Since the NRP2 pathway activation is thought to occur …
K Vosbeck, S Förster, T Mayr, A Sahu, EM Haddouti… - Cancers, 2024 - mdpi.com
Simple Summary Bone marrow (myelo-) fibrosis in myeloproliferative neoplasms is associated with poor prognosis and treatment failure emphasizing the importance of …
Abstract (DE) Als viert häufigste Karzinomerkrankung bei Männern und zwölft häufigste bei Frauen in Deutschland ist das BCa weitverbreitet in der Gesellschaft. Dies …